13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • ORAL MUCOSITIS Head and Neck

    Acronym: 

    ORAL MUCOSITIS

    ACTRN/NCT /ethics: 

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type Head and Neck
    Trial Type Treatment
    Phase Phase II, Phase I Tumour Stream Head and Neck
    Age Range 18 years and older Cancer Stage Clinical Trials - Cancer Stage
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Head and Neck
    Trial Type Treatment
    Phase Phase II, Phase I
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Head and Neck
    Cancer Stage Clinical Trials - Cancer Stage
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    A phase 1b/2, multicanter, randomised study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of ST-617 for the attenuation of oral mucositis in patients receiving chemoradiation for head and neck cancer

    Lay Summary

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Shawgi Sukumaran Not Yet Recruiting